Skip to content
lifestyle.lamora.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Biovica International
Biovica Expands Master Services Agreement with a Current Customer, a Leading Global Pharmaceutical Company, to Support Next-Generation Oncology Development
July 7, 2026
Biovica Granted Japanese Patent for Immuno-Oncology
July 1, 2026
Biovica Refocuses US Commercial Strategy and Terminates Agreement with Tempus AI
June 30, 2026
Correction: Biovica Refocuses US Commercial Strategy and Terminates Agreement with Tempus AI
June 30, 2026
Biovica International AB – Annual Report for The Financial Year 2025/2026 Published
June 30, 2026
Year-End Report 2025-2026
June 17, 2026
New phase III Translational Data Show DiviTum(R) TKa Captures Treatment-Specific Biological Response in Metastatic Breast Cancer
June 6, 2026
Biovica Receives Expanded Work Order from Clinical-Stage Oncology Company for Next-Generation CDK Inhibitor Program
June 6, 2026
Biovica International AB Announces Change in Executive Management
May 24, 2026
New ESMO Data Highlights TKa Across Multiple Treatment Settings
May 20, 2026
←
Previous Page
1
2
3